Supplementary Data from First-in-Human, Phase 1 Dose-Escalation Study of Biparatopic Anti-HER2 Antibody–Drug Conjugate MEDI4276 in Patients with HER2-positive Advanced Breast or Gastric Cancer

Mark D. Pegram,Erika P. Hamilton,Antoinette R. Tan,Anna Maria Storniolo, Kemal Balic,Anton I. Rosenbaum,Meina Liang,Peng He,Shannon Marshall,Anita Scheuber,Mayukh Das,Manish R. Patel

crossref（2023）

引用 0|浏览5

暂无评分

摘要

Supplementary Data from First-in-Human, Phase 1 Dose-Escalation Study of Biparatopic Anti-HER2 Antibody–Drug Conjugate MEDI4276 in Patients with HER2-positive Advanced Breast or Gastric Cancer

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要